Imricor's successful iCMR-guided ablation at Dubrava University Hospital

Imricor Medical Systems, Inc. (ASX: $IMR) has announced the successful completion of the second iCMR-guided atrial flutter ablation at Dubrava University Hospital in Zagreb, Croatia. Following the commencement of iCMR guided ablations last week, Dubrava has already ordered ten additional Vision-MR Ablation Catheter kits to support their ramp up as iCMR guided procedures become routine at this site.

Imricor's CEO on sales goals and technology launch

Our sales goals this year are focused on activating more sites each quarter, and ensuring consistent procedure volume at each active site. This is how we start to establish a new standard of care. The activation process involves several steps, starting with the purchase and installation of our iCMR EP lab equipment, which generates capital revenue for Imricor. As consistent procedures follow, so does Imricor's recurring consumable revenue, which is now building momentum across the business in line with our stated objective in Q1. Today is the latest example of our sales team fulfilling their goals and successfully launching our groundbreaking technology across Europe.

Imricor's outlook and corporate strategy

Imricor's successful iCMR-guided ablation at Dubrava University Hospital marks a significant milestone in their objective to establish a new standard of care. With more patients already scheduled for the coming weeks, the company's recurring consumable revenue is building momentum in line with their stated objective in Q1. The additional purchase order for catheter kits reflects the increasing demand for their products, indicating a positive outlook for Imricor's corporate strategy and the adoption of their groundbreaking technology across Europe.